Scripps, Johnson & Johnson join forces in drug development effort

Scripps, Johnson & Johnson join forces in drug development effort

April 14, 2014 10:46 am by | 0 Comments

JUPITER — In an effort to spur start-up biotech companies, Scripps Florida said Monday that it has created a new venture and has partnered with a big-name drug firm. The…


High cost of potent Hepatitis drug presents challenges across the U.S.

High cost of potent Hepatitis drug presents challenges across the U.S.

April 14, 2014 9:39 am by | 0 Comments

Sovaldi, the hepatitis C treatment drug, is considered a breakthrough for patients with the disease. However, since, it won federal approval in December, lawmakers, insurers and patient advocates have begun…



Study: 25 percent of Colorado foster kids on psychotropic drugs

Study: 25 percent of Colorado foster kids on psychotropic drugs

April 14, 2014 9:39 am by | 0 Comments

The rate is 12 times greater than for other children on government insurance, a new study in Colorado finds. The Associated Press:  25% Of Colorado Foster Kids On Psychotropic A…


Maryland’s marijuana laws leave unanswered questions

Maryland’s marijuana laws leave unanswered questions

April 14, 2014 6:16 am by | 0 Comments

Now that the state’s medical marijuana program has been revived, officials say it will take about 15 months for the first patients to buy the drug legally in Maryland. Shannon…


Independent pharmacy hoping to carve niche over big box stores

Independent pharmacy hoping to carve niche over big box stores

April 13, 2014 9:03 am by | 0 Comments

Miss. — A customer looking to fill a prescription doesn’t have to look hard these days. The nation’s largest pharmacies, Walgreens and CVS, battle for prime locations; big-box retailers like…


Payers, providers, patients – even politicians – attacking Gilead over $1,000/day hepatitis C pill

Payers, providers, patients – even politicians – attacking Gilead over $1,000/day hepatitis C pill

April 13, 2014 8:19 am by | 3 Comments

The nation may have finally met a drug it cannot afford.
Sovaldi is a long-awaited breakthrough for the 3 million Americans suffering from the hepatitis C virus. And at $1,000 a daily pill, or $84,000 over 12 weeks of treatment, the medication could ge…


‘Molecular tweezers:’ A potential new strategy for fending off Alzheimer’s?

‘Molecular tweezers:’ A potential new strategy for fending off Alzheimer’s?

April 11, 2014 5:52 am by | 0 Comments

Rather than trying to break up clumps of proteins that characterize many brain diseases including Parkinson’s and Alzheimer’s disease, Gal Bitan and his team are trying to stop them from…



Lancet studies: Nostrils, vaginas built from patients’ own tissues are working well after implantation

Lancet studies: Nostrils, vaginas built from patients’ own tissues are working well after implantation

April 11, 2014 4:25 am by | 0 Comments

LONDON (AP) — Two new studies describe the latest achievements in growing body parts in a lab and transplanting them into people, this time with nostrils and vaginas. Windpipes, bladders,…


GPhA calls for US-EU convergence in biosimilar and generic medicine regulation

GPhA calls for US-EU convergence in biosimilar and generic medicine regulation

April 10, 2014 10:48 pm by | 0 Comments

By James C. Shehan – The Generic Pharmaceuticals Association (“GPhA”) opened a new front in its ongoing battle to shape the approval process for biosimilars, while also calling for more…


JNJ, BioCrossroads invest in Hoosier pharma startup at work on potential hepatitis B cure

JNJ, BioCrossroads invest in Hoosier pharma startup at work on potential hepatitis B cure

April 10, 2014 5:26 pm by | 0 Comments

An Indiana University spinout attracted investors from Johnson & Johnson Development Corp. and BioCrossroads with novel drugs to treat, and even potentially cure, patients with hepatitis B. Assembly Pharmaceuticals received an undisclosed…


Creating health: avoiding the trap of lazy superiority

Creating health: avoiding the trap of lazy superiority

April 10, 2014 10:00 am by | 0 Comments

I’m finding it hard to start this post because I have to start with an admission. It’s an admission of laziness, of presumed superiority. In many ways I have slipped…


Chimerix CMO steps up to take over president and CEO job

Chimerix CMO steps up to take over president and CEO job

April 10, 2014 3:53 am by | 0 Comments

DURHAM — Durham-based Chimerix Inc. has named a successor for CEO Ken Moch, who is resigning about a month after a family’s request for access to the company’s experimental drug brincidofovir to save their 8-year-old son drew national attention.
While…


UW spinout is hoping a drug could stave off hearing loss caused by antibiotics

UW spinout is hoping a drug could stave off hearing loss caused by antibiotics

April 9, 2014 4:05 pm by | 0 Comments

University of Washington spinout Oricula Therapeutics said today it’s secured funding and intellectual property that will allow it to move forward with developing a way to prevent hearing loss associated…


Maine Pharmacy Association claims Canadian company sells prescriptions filled in India

Maine Pharmacy Association claims Canadian company sells prescriptions filled in India

April 9, 2014 2:39 pm by | 0 Comments

The president of the Maine Pharmacy Association has filed a complaint with state regulators alleging that a Canadian company broke state law by selling him generic drugs from prescriptions that were filled in India, Turkey and Mauritius.
In a complaint…


Spero Therapeutics catches Roche’s eye with a new way to target drug-resistant bacterial infections

Spero Therapeutics catches Roche’s eye with a new way to target drug-resistant bacterial infections

April 9, 2014 11:42 am by | 0 Comments

Overcoming challenges posed by the growing number of infections that are resistant to traditional antibiotics is the goal of a startup surfacing today with a $3 million Series A and…